Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer

(2009) G. Viale et al.   ANNALS OF ONCOLOGY

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer

(2009) So-Youn Jung et al.   ANNALS OF SURGICAL ONCOLOGY

Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004

(2009) Carol A. Parise et al.   Breast Journal

Clinical relevance of the triple-negative breast cancer concept: Genetic basis and clinical utility of the concept

(2009) Sabine C. Linn et al.   EUROPEAN JOURNAL OF CANCER

Potential for False-Positive Staining With a Rabbit Monoclonal Antibody to Progesterone Receptor (SP2)

(2008) Merdol Ibrahim et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial

(2008) M. Schmidt et al.   ANNALS OF ONCOLOGY

The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004

(2008) Monica Brown et al.   CANCER

Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast Cancer

(2008) Chaitanya R. Acharya   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Does Estrogen Receptor–Negative/Progesterone Receptor–Positive Breast Carcinoma Exist?

(2008) Leen De Maeyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of the prognostic value of 2005 St Gallen risk categories for operated breast cancers in Hong Kong

(2007) T.K. Yau et al.   BREAST